Cetrorelix: all 40 studies that test it
Page 1 of 1. Open to participants first (2), then studies with results posted, then the rest; newest registration first within each.
- Effectiveness of Generic Versus Reference Cetrorelix Acetate for Ovarian Stimulation Using a Gonadotropin-releasing Hormone（GnRH）Antagonist Protocol in Women Undergoing IVFRecruitingNCT06023602Not applicable
- Sex Differences in Myocardial Steatosis Induced Left Ventricular DysfunctionRecruitingNCT04671966Phase 4
- Progestin Primed Double Stimulation Protocol Versus Flexible GnRH Antagonist Protocol in Poor RespondersCompletedNCT04537078Phase 3Results posted
- Outcome of Cetrotide Therapy for Management of Women at High-risk of Ovarian Hyperstimulation SyndromeStatus unknownNCT02823080Phase 2/3Results posted
- Dysregulation of FSH in Obesity: Functional and Statistical AnalysisCompletedNCT02478775Not applicableResults posted
- Reproductive Hormonal Alterations in ObesityCompletedNCT01457703Not applicableResults posted
- Analysis of Two Therapeutic With Cetrotide® in Polycystic Ovarian (PCO) Women in Assisted Reproductive Technology (ART)CompletedNCT01185704Phase 3Results posted
- The Role of Cetrotide Acetate in Prevention of Ovarian Hyperstimulation Syndrome (OHSS) in Oocyte DonorsCompletedNCT00867659Not applicableResults posted
- Cetrotide Treatment OptimizationTerminatedNCT00866034Phase 4Results posted
- Cetrorelix Pamoate IM Regimens in Patients With Symptomatic Benign Prostatic Hyperplasia (BPH)CompletedNCT00670306Phase 3Results posted
- Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)TerminatedNCT00449150Phase 3Results posted
- PPOS vs GnRH Antagonist in Ovarian Stimulation (ProGanOS Study)Active, not recruitingNCT06378268Not applicable
- Progestin-primed Ovarian Stimulation Protocol Versus GnRH Antagonist Protocol in Polycystic Ovary Syndrome Patients Undergoing IVF/ICSI CyclesStatus unknownNCT05112692Not applicable
- Effect of GnRH Agonist vs GnRH Antagonist on Oocyte Morphology in Polycystic Ovary Syndrome Patients During IVF/ICSICompletedNCT04727684Phase 4
- Effect of GnRH Agonist vs GnRH Antagonist on IVF/ICSI Outcomes in Polycystic Ovary Syndrome Patients.CompletedNCT04727671Phase 4
- Effect of GnRH Agonist vs GnRH Antagonist on Oocyte Morphology During IVF/ICSICompletedNCT04724486Phase 4
- Effect of GnRH Agonist vs GnRH Antagonist on IVF/ICSI Outcomes.CompletedNCT04724343Phase 4
- The Aromatase Inhibitor and Gnrh Antagonist Versus Methotrexate for Management of Undisturbed Ectopic PregnancyStatus unknownNCT04308343Not applicable
- Frozen Embryo Transfer With GnRH-antagonist TrialStatus unknownNCT03763786Phase 4
- Efficacy of Growth Hormone Supplementation With Gonadotrophins in IVF/ICSI for Poor RespondersCompletedNCT03759301Phase 4
- Cetrorelix and Ganirelix Flexible Protocol for (IVF)Status unknownNCT03477929Phase 4
- Long Protocol and Freeze All Embryos vs Antagonist Protocol With Fresh Embryo Transfer in PCOS Patients Undergoing ICSICompletedNCT03118830Phase 4
- NATural Ovarian StimulationCompletedNCT02892942Phase 4
- Gonadotropin Releasing Hormone Antagonist in Treatment of Early-onset Severe Ovarian Hyperstimulation SyndromeCompletedNCT02784457Phase 2
- Poor Ovarian Stimulation Response in In Vitro Fertilization (IVF) ProgramCompletedNCT02640976Early Phase 1
- Luteal Antagonist Versus Conventional Treatment in Women With Severe Early Ovarian Hyperstimulation Syndrome (OHSS)Status unknownNCT02392520Not applicable
- Delayed Start Versus Conventional Antagonist Protocol in Poor Responders Pretreated by Estradiol in Luteal PhaseCompletedNCT02333253Phase 3
- Sex Hormones and Atherosclerosis Prevention in Perimenopausal WomenCompletedNCT02042196Early Phase 1
- Study on Influence of Leutinizing Hormone (LH) on Oocyte MaturityStatus unknownNCT01595334Not applicable
- Comparing Ovarian Stimulation for Assisted Reproduction With Two Different Forms of Pituitary SuppressionCompletedNCT01565265Not applicable
- Administration of Increased Dose of GnRH Antagonist for Coasting for Decreasing the Risk for Ovarian Hyperstimulation Syndrome( OHSS)WithdrawnNCT01109888Phase 1/2
- Fixed Versus Flexible Gonadotropin-releasing Hormone (GnRH) Antagonist InitiationCompletedNCT01005784Phase 4
- Novel MRI Strategies as a Non-invasive Biomarker in Women With Uterine FibroidsCompletedNCT00746031Phase 4
- Gonadotropin-Releasing Hormone (GnRH)-Antagonist Therapy in Rheumatoid ArthritisCompletedNCT00667758Phase 2
- Clinical Pharmacological Study of GnRH Antagonist, Cetrorelix for Healthy Female VolunteerCompletedNCT00628121Not applicable
- Gonadotropin-releasing Hormone Antagonist on Triggering Day: A Randomized Controlled StudyCompletedNCT00571870Not applicable
- GnRH Agonist and Antagonists in an Oocyte Donation ProgramCompletedNCT00505817Phase 4
- Synchronization of Follicle Wave Emergence and Ovarian StimulationCompletedNCT00439829Phase 4
- A Study to Compare the Safety and Efficacy of Cetrotide® 3 Milligram (mg) Versus Antagon™ in Women Undergoing Ovarian StimulationCompletedNCT00298025Phase 4
- A Multinational, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Investigate the Efficacy, Safety and Duration of Effect of a Single Administration of Various Doses of Cetrorelix SR in Subjects With Histologically Confirmed EndometriosisCompletedNCT00244452Phase 2